1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice
Latest trending news Ask a Whistleblower Attorney forum

Northern Cal/San Francisco

  1. General Discussion - Northern Cal/SF

    Discussions:
    0
    Messages:
    0
    (Contains no messages)
    RSS

  2. Jobs & Business Opportunities - Northern Cal/SF

    Discussions:
    2
    Messages:
    2
    Latest: Pharmaceutical Marketing Auditor (San Francisco Area) pharmalaw, Oct 8, 2019 at 10:40 AM
    RSS